Literature DB >> 28900803

Making Decisions About Medication Use During Pregnancy: Implications for Communication Strategies.

Molly M Lynch1, Linda B Squiers2, Katherine M Kosa2, Suzanne Dolina2, Jennifer Gard Read2, Cheryl S Broussard3, Meghan T Frey3, Kara N Polen3, Jennifer N Lind3,4, Suzanne M Gilboa3, Janis Biermann5.   

Abstract

Objective To explore women's perceptions of the risks and benefits associated with medication use during pregnancy and to better understand how women make decisions related to medication use in pregnancy. Methods We conducted online focus groups with 48 women who used medication during pregnancy or while planning a pregnancy, and 12 in-depth follow-up interviews with a subset of these women. Results We found that women were aware of general risks associated with medication use but were often unable to articulate specific negative outcomes. Women were concerned most about medications' impact on fetal development but were also concerned about how either continuing or discontinuing medication during pregnancy could affect their own health. Women indicated that if the risk of a given medication were unknown, they would not take that medication during pregnancy. Conclusion This formative research found that women face difficult decisions about medication use during pregnancy and need specific information to help them make decisions. Enhanced communication between patients and their providers regarding medication use would help address this need. We suggest that public health practitioners develop messages to (1) encourage, remind, and prompt women to proactively talk with their healthcare providers about the risks of taking, not taking, stopping, or altering the dosage of a medication while trying to become pregnant and/or while pregnant; and (2) encourage all women of childbearing age to ask their healthcare providers about medication use.

Entities:  

Keywords:  Chronic disease; Medication; Preconception health; Pregnancy

Mesh:

Substances:

Year:  2018        PMID: 28900803      PMCID: PMC5764786          DOI: 10.1007/s10995-017-2358-0

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  16 in total

1.  Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008.

Authors:  Allen A Mitchell; Suzanne M Gilboa; Martha M Werler; Katherine E Kelley; Carol Louik; Sonia Hernández-Díaz
Journal:  Am J Obstet Gynecol       Date:  2011-04-22       Impact factor: 8.661

Review 2.  Principles and practice of teratology for the obstetrician.

Authors:  Barbra Fisher; Nancy C Rose; John C Carey
Journal:  Clin Obstet Gynecol       Date:  2008-03       Impact factor: 2.190

3.  Management of prescription and nonprescription drug use during pregnancy.

Authors:  Maria A Morgan; Janet D Cragan; Robert L Goldenberg; Sonja A Rasmussen; Jay Schulkin
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08

Review 4.  Evolving knowledge of the teratogenicity of medications in human pregnancy.

Authors:  Margaret P Adam; Janine E Polifka; J M Friedman
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-07-15       Impact factor: 3.908

5.  Pregnant women's beliefs about medications--a study among 866 Norwegian women.

Authors:  Hedvig Nordeng; Gideon Koren; Adrienne Einarson
Journal:  Ann Pharmacother       Date:  2010-08-24       Impact factor: 3.154

6.  The use during pregnancy of prescription, over-the-counter, and alternative medications among Hispanic women.

Authors:  Jennifer Bercaw; Bani Maheshwari; Haleh Sangi-Haghpeykar
Journal:  Birth       Date:  2010-09       Impact factor: 3.689

7.  Pattern of drug use during the first trimester among Chinese women: data from a population-based cohort study.

Authors:  Xiaoming Zhu; Xiuyu Qi; Jiahu Hao; Zhaohui Huang; Zhihua Zhang; Xiuya Xing; Daijuan Cheng; Limin Xiao; Yuanyuan Xu; Peng Zhu; Fangbiao Tao
Journal:  Eur J Clin Pharmacol       Date:  2010-02-02       Impact factor: 2.953

8.  Women's perspectives on counseling about risks for medication-induced birth defects.

Authors:  Aimee K Santucci; Melanie A Gold; Aletha Y Akers; Sonya Borrero; Eleanor Bimla Schwarz
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-01

9.  Study of awareness among pregnant women of the effects of drugs on the fetus and mother in Iran.

Authors:  Simin O Mashayekhi; Maryam Dilmaghanizadeh; Zahra Fardiazar; Roghayeh Bamdad-Moghadam; Fahimeh Ghandforoush-Sattari
Journal:  Health Policy       Date:  2009-01-06       Impact factor: 2.980

10.  Women's beliefs about medication use during their pregnancy: a UK perspective.

Authors:  M J Twigg; A Lupattelli; H Nordeng
Journal:  Int J Clin Pharm       Date:  2016-05-30
View more
  16 in total

Review 1.  Enhancing uptake of influenza maternal vaccine.

Authors:  Mallory K Ellingson; Matthew Z Dudley; Rupali J Limaye; Daniel A Salmon; Sean T O'Leary; Saad B Omer
Journal:  Expert Rev Vaccines       Date:  2019-01-28       Impact factor: 5.217

2.  Identification of At-risk Pregnant Population for Over-the-Counter Drug Usage in Low-Resource Settings.

Authors:  Aashima Arora; M Praveen Kumar; Aishwarya Anand; Lekha Saha; Pradip Kumar Saha; Ankit Kumar; Haresh Shendge; Amol N Patil
Journal:  J Obstet Gynaecol India       Date:  2021-05-02

3.  Impact of a Mobile Application for Tracking Nausea and Vomiting During Pregnancy (NVP) on NVP Symptoms, Quality of Life, and Decisional Conflict Regarding NVP Treatments: MinSafeStart Randomized Controlled Trial.

Authors:  Elin Ngo; Maria Bich-Thuy Truong; Hedvig Nordeng; David Wright
Journal:  JMIR Mhealth Uhealth       Date:  2022-07-05       Impact factor: 4.947

4.  Racial/Ethnic Differences in Prenatal Supplement and Medication Use in Low-Risk Pregnant Women.

Authors:  Yassaman Vafai; Edwina H Yeung; Rajeshwari Sundaram; Melissa M Smarr; Nicole Gerlanc; William A Grobman; Daniel Skupski; Edward K Chien; Stefanie N Hinkle; Roger B Newman; Deborah A Wing; Angela C Ranzini; Anthony Sciscione; Jagteshwar Grewal; Cuilin Zhang; Katherine L Grantz
Journal:  Am J Perinatol       Date:  2020-10-08       Impact factor: 3.079

5.  Adherence to and Persistence with Antidepressant Medication during Pregnancy: Does It Differ by the Class of Antidepressant Medication Prescribed?

Authors:  Kamala Adhikari; Scott B Patten; Sangmin Lee; Amy Metcalfe
Journal:  Can J Psychiatry       Date:  2018-09-25       Impact factor: 4.356

6.  Sterol Biosynthesis Inhibition in Pregnant Women Taking Prescription Medications.

Authors:  Thiago C Genaro-Mattos; Korinne B Klingelsmith; Luke B Allen; Allison Anderson; Keri A Tallman; Ned A Porter; Zeljka Korade; Károly Mirnics
Journal:  ACS Pharmacol Transl Sci       Date:  2021-02-17

7.  "I know my body better than you:" patient focus groups to inform a decision aid on oral corticosteroid use during pregnancy.

Authors:  Kristin Palmsten; Dani Bredesen; Meghan M JaKa; Pritika C Kumar; Jeanette Y Ziegenfuss; Elyse O Kharbanda
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-12-22       Impact factor: 2.890

8.  Agreement and Disparities between Women and Stop-Smoking Specialists about How to Promote Adherence to Nicotine Replacement Therapy in Pregnancy.

Authors:  Lisa McDaid; Ross Thomson; Joanne Emery; Tim Coleman; Sue Cooper; Lucy Phillips; Felix Naughton
Journal:  Int J Environ Res Public Health       Date:  2021-04-28       Impact factor: 3.390

9.  A Learning Healthcare System for pregnant and breastfeeding women: what do women during preconception, pregnancy, and nursing think? - A qualitative study : A contribution from the ConcePTION project.

Authors:  Marieke J Hollestelle; Rieke van der Graaf; Sarah Dewi Hartman; Miriam C J M Sturkenboom; Johannes J M van Delden
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-18       Impact factor: 3.105

10.  Risk perception, beliefs about medicines and medical adherence among pregnant and breastfeeding women with migraine: findings from a cross-sectional study in Norway.

Authors:  Siri Amundsen; Torunn Gudmestad Øvrebø; Netta Marie Skretteberg Amble; Anne Christine Poole; Hedvig Nordeng
Journal:  BMJ Open       Date:  2019-02-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.